David Santimaw

David Santimaw serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical scientific and technical services. He manages a diverse portfolio of contracts focused on laboratory diagnostics, biomedical research support, and data-driven public health operations, ensuring timely access to high-integrity capabilities in infectious disease detection and surveillance. His work directly enables CDC’s rapid response infrastructure by facilitating the acquisition of specialized services that underpin national health security efforts. Santimaw maintains consistent working relationships with leading providers in the public health and life sciences sectors, including General Dynamics Information Technology, Inc., Cepheid, MRIGLOBAL, GlaxoSmithKline, LLC, and New York City Health & Hospitals Corp. These partnerships reflect a preference for established vendors with proven expertise in clinical diagnostics, molecular testing, and epidemiological data systems. His contracting approach emphasizes performance-based outcomes, rigorous compliance with federal acquisition regulations, and long-term vendor collaboration to ensure continuity in mission-critical operations. His procurement strategy prioritizes open competition, with approximately 80% of acquisitions conducted without set-asides, while maintaining a deliberate 20% allocation to total small business set-asides under FAR 19.5. This balanced approach ensures access to innovative small business capabilities while preserving the scale and reliability required for national health emergencies. He actively promotes socioeconomic inclusion by engaging qualified small businesses in technical and laboratory support roles without compromising operational readiness. Santimaw’s primary procurement focus lies in NAICS 541511 (Custom Computer Programming Services) and 621511 (Medical Laboratories), each accounting for 40% of his portfolio, with additional emphasis on 541690 (Other Scientific and Technical Consulting Services). He specializes in acquiring bioinformatics platforms, laboratory automation systems, real-time disease surveillance software, and analytical consulting services that enhance CDC’s capacity to interpret complex public health data and deploy targeted interventions.